{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:20:43Z","timestamp":1782976843045,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente 2024\u20132026"],"award-info":[{"award-number":["Ricerca Corrente 2024\u20132026"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06464-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:28:40Z","timestamp":1745933320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-8578","authenticated-orcid":false,"given":"Giuseppe","family":"Lisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-3686","authenticated-orcid":false,"given":"Davide","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8524-3709","authenticated-orcid":false,"given":"Nicole","family":"Cerabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2759-8347","authenticated-orcid":false,"given":"Martina","family":"Di Chito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Donvito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-348X","authenticated-orcid":false,"given":"Caterina","family":"Bonfiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-0436","authenticated-orcid":false,"given":"Endrit","family":"Shahini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Zappimbulso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-6190","authenticated-orcid":false,"given":"Cristiana","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0259-9799","authenticated-orcid":false,"given":"Dolores","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7662-1763","authenticated-orcid":false,"given":"Anna","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Coletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4675-2075","authenticated-orcid":false,"given":"Pasqua Letizia","family":"Pesole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-8060","authenticated-orcid":false,"given":"Gianluigi","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-3273","authenticated-orcid":false,"given":"Giovanni","family":"De Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"6464_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20517\/mtod.2024.57","volume":"4","author":"RJ Wong","year":"2024","unstructured":"Wong RJ. Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD). Metab Target Organ Damage. 2024;4:35. https:\/\/doi.org\/10.20517\/mtod.2024.57.","journal-title":"Metab Target Organ Damage"},{"key":"6464_CR2","doi-asserted-by":"publisher","first-page":"107375","DOI":"10.1016\/j.phrs.2024.107375","volume":"208","author":"N Sharma","year":"2024","unstructured":"Sharma N, Singh L, Sharma A, Kumar A, Mahajan D. NAFLD-associated hepatocellular carcinoma (HCC) - A compelling case for repositioning of existing mTORc1 inhibitors. Pharmacol Res. 2024;208:107375. https:\/\/doi.org\/10.1016\/j.phrs.2024.107375.","journal-title":"Pharmacol Res"},{"issue":"8","key":"6464_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","volume":"19","author":"MP Manns","year":"2022","unstructured":"Manns MP, Maasoumy B. Breakthroughs in hepatitis C research: from discovery to cure. Nat Rev Gastroenterol Hepatol. 2022;19(8):533\u201350. https:\/\/doi.org\/10.1038\/s41575-022-00608-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"6464_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20(1):37\u201349. https:\/\/doi.org\/10.1038\/s41575-022-00688-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6464_CR5","doi-asserted-by":"publisher","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab 2024, 35(8), 697\u201307. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007","DOI":"10.1016\/j.tem.2024.02.007"},{"issue":"1","key":"6464_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"7","key":"6464_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","volume":"28","author":"J Quek","year":"2022","unstructured":"Quek J, Ng CH, Tang ASP, Chew N, Chan M, Khoo CM, Wei CP, Chin YH, Tay P, Lim G, Tan DJH, Lim WH, Chan KE, Teng M, Tan E, Tamaki N, Huang DQ, Siddiqui MS, Young DY, Noureddin M, Muthiah MD. Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A Meta-Analysis and systematic review of 12 620 736 individuals. Endocr Pract. 2022;28(7):667\u201372. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.016.","journal-title":"Endocr Pract"},{"issue":"7","key":"6464_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11892-024-01542-6","volume":"24","author":"Y Castillo-N\u00fa\u00f1ez","year":"2024","unstructured":"Castillo-N\u00fa\u00f1ez Y, Almeda-Valdes P, Gonz\u00e1lez-G\u00e1lvez G, Arechavaleta-Granell MDR. Metabolic dysfunction-associated steatotic liver disease and atherosclerosis. Curr Diab Rep. 2024;24(7):158\u201366. https:\/\/doi.org\/10.1007\/s11892-024-01542-6.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"6464_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","volume":"61","author":"A Tripodi","year":"2014","unstructured":"Tripodi A, Fracanzani AL, Primignani M, Chantarangkul V, Clerici M, Mannucci PM, Peyvandi F, Bertelli C, Valenti L, Fargion S. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. J Hepatol. 2014;61(1):148\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2014.03.013.","journal-title":"J Hepatol"},{"issue":"4","key":"6464_CR10","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/cphy.c160004","volume":"6","author":"H Kaji","year":"2016","unstructured":"Kaji H. Adipose Tissue-Derived plasminogen activator Inhibitor-1 function and regulation. Compr Physiol. 2016;6(4):1873\u201396. https:\/\/doi.org\/10.1002\/cphy.c160004.","journal-title":"Compr Physiol"},{"issue":"24","key":"6464_CR11","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","volume":"342","author":"HP Kohler","year":"2000","unstructured":"Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med. 2000;342(24):1792\u2013801. https:\/\/doi.org\/10.1056\/NEJM200006153422406.","journal-title":"N Engl J Med"},{"issue":"11","key":"6464_CR12","doi-asserted-by":"publisher","first-page":"e26762","DOI":"10.1371\/journal.pone.0026762","volume":"6","author":"H Brogren","year":"2011","unstructured":"Brogren H, Wallmark K, Deinum J, Karlsson L, Jern S. Platelets retain high levels of active plasminogen activator inhibitor 1. PLoS ONE. 2011;6(11):e26762. https:\/\/doi.org\/10.1371\/journal.pone.0026762.","journal-title":"PLoS ONE"},{"issue":"1","key":"6464_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ajh.10314","volume":"73","author":"IS Jovin","year":"2003","unstructured":"Jovin IS, Willuweit A, Taborski U, Lehnhardt A, Schreiner K, Kl\u00f6vekorn WP, M\u00fcller-Berghaus G. Low-density lipoproteins induce the Polar secretion of PAI-1 by endothelial cells in culture. Am J Hematol. 2003;73(1):66\u20138. https:\/\/doi.org\/10.1002\/ajh.10314.","journal-title":"Am J Hematol"},{"key":"6464_CR14","doi-asserted-by":"publisher","unstructured":"Huang J, Sabater-Lleal M, Asselbergs FW, Tregouet D, Shin SY, Ding J, Baumert J, Oudot-Mellakh T, Folkersen L, Johnson AD, Smith NL, Williams SM, Ikram MA, Kleber ME, Becker DM, Truong V, Mychaleckyj JC, Tang W, Yang Q, Sennblad B, Moore JH, Williams FM, Dehghan A, Silbernagel G, Schrijvers EM, Smith S, Karakas M, Tofler GH, Silveira A, Navis GJ, Lohman K, Chen MH, Peters A, Goel A, Hopewell JC, Chambers JC, Saleheen D, Lundmark P, Psaty BM, Strawbridge RJ, Boehm BO, Carter AM, Meisinger C, Peden JF, Bis JC, McKnight B, \u00d6hrvik J, Taylor K, Franzosi MG, Seedorf U, Collins R, Franco-Cereceda A, Syv\u00e4nen AC, Goodall AH, Yanek LR, Cushman M, M\u00fcller-Nurasyid M, Folsom AR, Basu S, Matijevic N, van Gilst WH, Kooner JS, Hofman A, Danesh J, Clarke R, Meigs JB, DIAGRAM Consortium, Kathiresan S, Reilly MP, CARDIoGRAM Consortium, Klopp N, Harris TB, Winkelmann BR, Grant PJ, Hillege HL, Watkins H; C4, D Consortium, Spector TD, Becker LC, Tracy RP, M\u00e4rz W, Uitterlinden AG, Eriksson P, Cambien F; CARDIOGENICS Consortium;, Morange PE, Koenig W, Soranzo N., van der Harst P, Liu Y, O\u2019Donnell CJ, Hamsten A. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood. 2012, 120(24), 4873-81. https:\/\/doi.org\/10.1182\/blood-2012-06-436188","DOI":"10.1182\/blood-2012-06-436188"},{"issue":"8","key":"6464_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/oby.2002.98","volume":"10","author":"N Pannacciulli","year":"2002","unstructured":"Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects. Obes Res. 2002;10(8):717\u201325. https:\/\/doi.org\/10.1038\/oby.2002.98.","journal-title":"Obes Res"},{"issue":"7","key":"6464_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","volume":"23","author":"MC Alessi","year":"2003","unstructured":"Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol. 2003;23(7):1262\u20138. https:\/\/doi.org\/10.1161\/01.ATV.0000077401.36885.BB.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"6464_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1464-5491.2005.01646.x","volume":"22","author":"G Targher","year":"2005","unstructured":"Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med. 2005;22(10):1354\u20138. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01646.x.","journal-title":"Diabet Med"},{"issue":"10","key":"6464_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/BF03349221","volume":"30","author":"S Yener","year":"2007","unstructured":"Yener S, Akarsu M, Demir T, Akinci B, Sagol O, Bayraktar F, Ozcan MA, Tankurt E, Yesil S. Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. J Endocrinol Invest. 2007;30(10):810\u20139. https:\/\/doi.org\/10.1007\/BF03349221.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"6464_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/oby.2008.64","volume":"16","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Rodella S, Lippi G, Franchini M, Zoppini G, Muggeo M. Day C.P. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obes (Silver Spring). 2008;16(6):1394\u20139. https:\/\/doi.org\/10.1038\/oby.2008.64.","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"6464_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/hep.32274","volume":"76","author":"JG Stine","year":"2022","unstructured":"Stine JG, Schreibman IR, Faust AJ, Dahmus J, Stern B, Soriano C, Rivas G, Hummer B, Kimball SR, Geyer NR, Chinchilli VM, Loomba R, Schmitz K, Sciamanna C. NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology. 2022;76(1):172\u201385. https:\/\/doi.org\/10.1002\/hep.32274.","journal-title":"Hepatology"},{"issue":"3","key":"6464_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ. Body mass index: obesity, BMI, and health: A critical review. Nutr Today. 2015;50(3):117\u201328. https:\/\/doi.org\/10.1097\/NT.0000000000000092.","journal-title":"Nutr Today"},{"issue":"6","key":"6464_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042.","journal-title":"Gastroenterology"},{"issue":"3","key":"6464_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD). European association for the study of obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol"},{"issue":"7","key":"6464_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","volume":"19","author":"TM Wallace","year":"2002","unstructured":"Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527\u201334. https:\/\/doi.org\/10.1046\/j.1464-5491.2002.00745.x.","journal-title":"Diabet Med"},{"issue":"8","key":"6464_CR25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395. https:\/\/doi.org\/10.1249\/01.MSS.0000078924.61453.FB.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"6464_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver; Clinical Practice Guideline Panel","year":"2021","unstructured":"European Association for the Study of the Liver; Clinical Practice Guideline Panel. Chair:; EASL governing board representative:; panel members:. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u2013\u20092021 update. J Hepatol. 2021;75(3):659\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025.","journal-title":"J Hepatol"},{"issue":"2","key":"6464_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.14218\/JCTH.2014.00008","volume":"2","author":"Expert Panel on Liver Stiffness Measurement","year":"2014","unstructured":"Expert Panel on Liver Stiffness Measurement. Clinical application of transient elastography in the diagnosis of liver fibrosis: an expert panel review and opinion. J Clin Transl Hepatol. 2014;2(2):110\u20136. https:\/\/doi.org\/10.14218\/JCTH.2014.00008.","journal-title":"J Clin Transl Hepatol"},{"key":"6464_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fgene.2014.00187","volume":"5","author":"X Wang","year":"2014","unstructured":"Wang X. Firth logistic regression for rare variant association tests. Front Genet. 2014;5:187. https:\/\/doi.org\/10.3389\/fgene.2014.00187.","journal-title":"Front Genet"},{"key":"6464_CR29","unstructured":"R Core Team. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/; 2024 [accessed on 26 September 2024]."},{"issue":"1","key":"6464_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2021","unstructured":"Stekhoven DJ, Buehlmann P. MissForest - non-parametric missing value imputation for mixed-type data. Bioinformatics. 2021;28(1):112\u201318.","journal-title":"Bioinformatics"},{"issue":"10431","key":"6464_CR31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(23)02750-2.","journal-title":"Lancet"},{"issue":"16","key":"6464_CR32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","volume":"282","author":"A Must","year":"1999","unstructured":"Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523\u20139. https:\/\/doi.org\/10.1001\/jama.282.16.1523.","journal-title":"JAMA"},{"issue":"1","key":"6464_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12889-021-12449-2","volume":"22","author":"J Hecker","year":"2022","unstructured":"Hecker J, Freijer K, Hiligsmann M, Evers SMAA. Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life. BMC Public Health. 2022;22(1):46. https:\/\/doi.org\/10.1186\/s12889-021-12449-2.","journal-title":"BMC Public Health"},{"issue":"12","key":"6464_CR34","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41366-023-01376-4","volume":"47","author":"J Pearson-Stuttard","year":"2023","unstructured":"Pearson-Stuttard J, Banerji T, Capucci S, de Laguiche E, Faurby MD, Haase CL, Sommer Matthiessen K, Near AM, Tse J, Zhao X, Evans M. Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals. Int J Obes (Lond). 2023;47(12):1239\u201346. https:\/\/doi.org\/10.1038\/s41366-023-01376-4.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"6464_CR35","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1038\/s41598-022-08812-x","volume":"12","author":"T Limpijankit","year":"2022","unstructured":"Limpijankit T, Vathesatogkit P, Matchariyakul D, Wiriyatanakorn S, Siriyotha S, Thakkinstian A, Sritara P. Causal relationship of excess body weight on cardiovascular events through risk factors. Sci Rep. 2022;12(1):5269. https:\/\/doi.org\/10.1038\/s41598-022-08812-x.","journal-title":"Sci Rep"},{"issue":"4","key":"6464_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2213-8587(22)00033-X","volume":"10","author":"M Kivim\u00e4ki","year":"2022","unstructured":"Kivim\u00e4ki M, Strandberg T, Pentti J, Nyberg ST, Frank P, Jokela M, Ervasti J, Suominen SB, Vahtera J, Sipil\u00e4 PN, Lindbohm JV, Ferrie JE. Body-mass index and risk of obesity-related complex Multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022;10(4):253\u201363. https:\/\/doi.org\/10.1016\/S2213-8587(22)00033-X.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6464_CR37","doi-asserted-by":"publisher","unstructured":"Koskinas KC, Van Craenenbroeck EM, Antoniades C, Bl\u00fcher M, Gorter TM, Hanssen H, Marx N, McDonagh TA, Mingrone G, Rosengren A, Prescott EB. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur J Prev Cardiol. 2024;zwae279. https:\/\/doi.org\/10.1093\/eurjpc\/zwae279.","DOI":"10.1093\/eurjpc\/zwae279"},{"issue":"21","key":"6464_CR38","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP, American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing. Council on clinical cardiology; Council on epidemiology and prevention; and stroke Council. Obesity and cardiovascular disease: A scientific statement from the American heart association. Circulation. 2021;143(21):e984\u20131010. https:\/\/doi.org\/10.1161\/CIR.0000000000000973.","journal-title":"Circulation"},{"key":"6464_CR39","doi-asserted-by":"publisher","first-page":"200331","DOI":"10.1016\/j.ijcrp.2024.200331","volume":"23","author":"F Perone","year":"2024","unstructured":"Perone F, Spadafora L, Pratesi A, Nicolaio G, Pala B, Franco G, Ruzzolini M, Ambrosetti M. Obesity and cardiovascular disease: risk assessment, physical activity, and management of complications. Int J Cardiol Cardiovasc Risk Prev. 2024;23:200331. https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200331.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"23","key":"6464_CR40","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.jacc.2024.06.050","volume":"84","author":"C Gyldenkerne","year":"2024","unstructured":"Gyldenkerne C, Kahlert J, Thrane PG, Olesen KKW, Mortensen MB, S\u00f8rensen HT, Thomsen RW, Maeng M. 2-Fold more cardiovascular disease events decades before type 2 diabetes diagnosis: A nationwide registry study. J Am Coll Cardiol. 2024;84(23):2251\u201359. https:\/\/doi.org\/10.1016\/j.jacc.2024.06.050.","journal-title":"J Am Coll Cardiol"},{"key":"6464_CR41","doi-asserted-by":"publisher","first-page":"111911","DOI":"10.1016\/j.diabres.2024.111911","volume":"218","author":"D Guido","year":"2024","unstructured":"Guido D, Cerabino N, Di Chito M, Di Stasi V, De Nucci S, Shahini E, Giannuzzi V, Cozzolongo R, Coletta S, Stabile D, Ancona A, Longo G, Fontana L, Giannelli G, De Pergola G. Association between liver steatosis, fibrosis, and the onset of type 2 diabetes in overweight individuals: A fibroscan-based study in Southern Italy. Diabetes Res Clin Pract. 2024;218:111911. https:\/\/doi.org\/10.1016\/j.diabres.2024.111911.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"6464_CR42","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1016\/j.jtha.2023.06.017","volume":"21","author":"D Swan","year":"2023","unstructured":"Swan D, Lisman T, Tripodi A, Thachil J. The prothrombotic tendency of metabolic-associated fatty liver disease. J Thromb Haemost. 2023;21(11):3045\u201355. https:\/\/doi.org\/10.1016\/j.jtha.2023.06.017.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"6464_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Yong XJ, Zeng JN, Chew RW, Nah NWS, Kulkarni B, Siddiqui A, Dan MS, Wong YY, Sanyal VW, Noureddin AJ, Muthiah M, Ng M. Global prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(22)00317-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"6464_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jcp.22783","volume":"227","author":"AK Ghosh","year":"2012","unstructured":"Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol. 2012;227(2):493\u2013507. https:\/\/doi.org\/10.1002\/jcp.22783.","journal-title":"J Cell Physiol"},{"issue":"2","key":"6464_CR45","doi-asserted-by":"publisher","first-page":"e0148969","DOI":"10.1371\/journal.pone.0148969","volume":"11","author":"K Omori","year":"2016","unstructured":"Omori K, Hattori N, Senoo T, Takayama Y, Masuda T, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Kohno N. Inhibition of plasminogen activator Inhibitor-1 attenuates transforming growth Factor-\u03b2-Dependent epithelial mesenchymal transition and differentiation of fibroblasts to myofibroblasts. PLoS ONE. 2016;11(2):e0148969. https:\/\/doi.org\/10.1371\/journal.pone.0148969.","journal-title":"PLoS ONE"},{"issue":"1","key":"6464_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/ebm.2011.011255","volume":"237","author":"JI Beier","year":"2012","unstructured":"Beier JI, Arteel GE. Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism. Exp Biol Med (Maywood). 2012;237(1):1\u20139. https:\/\/doi.org\/10.1258\/ebm.2011.011255.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"6464_CR47","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1017\/S0007114523001940","volume":"131","author":"P Li","year":"2024","unstructured":"Li P, Huang Y, Wong A. Behavioural strategies to reduce obesity among lower socio-economic adults living in high-income countries: a grades of recommendation, assessment, development and Evaluation-assessed systematic review and meta-analysis of randomised controlled trials. Br J Nutr. 2024;131(3):544\u201352. https:\/\/doi.org\/10.1017\/S0007114523001940.","journal-title":"Br J Nutr"},{"issue":"6","key":"6464_CR48","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/MPG.0000000000001096","volume":"62","author":"JR Holzberg","year":"2016","unstructured":"Holzberg JR, Jin R, Le NA, Ziegler TR, Brunt EM, McClain CJ, Konomi JV, Arteel GE, Vos MB. Plasminogen activator Inhibitor-1 predicts quantity of hepatic steatosis independent of insulin resistance and body weight. J Pediatr Gastroenterol Nutr. 2016;62(6):819\u201323. https:\/\/doi.org\/10.1097\/MPG.0000000000001096.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"6464_CR49","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","volume":"1","author":"I Juhan-Vague","year":"2003","unstructured":"Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost. 2003;1(7):1575\u20139. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00279.x.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"6464_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/1520-7560(200005\/06)16:3<192::AID-DMRR114>3.0.CO;2-G","volume":"16","author":"JP Bastard","year":"2000","unstructured":"Bastard JP, Pi\u00e9roni L, Hainque B. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev. 2000;16(3):192\u2013201.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"6464_CR51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2009.06.026","volume":"208","author":"D Ardig\u00f2","year":"2010","unstructured":"Ardig\u00f2 D, Franzini L, Valtue\u00f1a S, Numeroso F, Piatti PM, Monti L, Reaven GM, Zavaroni I. The increase in plasma PAI-1 associated with insulin resistance May be mediated by the presence of hepatic steatosis. Atherosclerosis. 2010;208(1):240\u20135. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.06.026.","journal-title":"Atherosclerosis"},{"key":"6464_CR52","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3389\/fphar.2018.01087","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang L, Chen L, Liu Z, Liu Y, Luo M, Chen N, Deng X, Luo Y, He J, Zhang L, Hill MA, Li R, Wu J. PAI-1 exacerbates white adipose tissue dysfunction and metabolic dysregulation in high fat Diet-Induced obesity. Front Pharmacol. 2018;9:1087. https:\/\/doi.org\/10.3389\/fphar.2018.01087.","journal-title":"Front Pharmacol"},{"key":"6464_CR53","doi-asserted-by":"publisher","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","volume":"7","author":"M Sillen","year":"2020","unstructured":"Sillen M, Declerck PJ. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and Inhibition. Front Cardiovasc Med. 2020;7:622473. https:\/\/doi.org\/10.3389\/fcvm.2020.622473.","journal-title":"Front Cardiovasc Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06464-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:28:45Z","timestamp":1745933325000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06464-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6464"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06464-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the National Institute of Gastroenterology and Research Hospital (DDG-CE-502\/2005; DDG-CE-792\/2014, on 20May 2005 and 14 February 2014, respectively).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"487"}}